Filing Details

Accession Number:
0001179110-10-003486
Form Type:
4
Zero Holdings:
No
Publication Time:
2010-02-23 12:00:00
Reporting Period:
2010-02-19
Filing Date:
2010-02-23
Accepted Time:
2010-02-23 17:34:06
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1145460 Inverness Medical Innovations Inc IMA In Vitro & In Vivo Diagnostic Substances (2835) 043565120
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1208147 Peter Townsend 51 Sawyer Road, Suite 200
Waltham MA 02453
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2010-02-19 8,333 $28.03 8,333 No 4 M Direct
Common Stock Disposition 2010-02-19 8,333 $39.40 0 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Employee Stock Option (Right to Buy) Disposition 2010-02-19 8,333 $0.00 8,333 $28.03
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 2008-05-24 2015-05-23 No 4 M Direct
Footnotes
  1. This derivative security does not have a price.